Research updates from Edinburgh The 2025 Peripheral Nerve Society’s Annual Meeting took place in Edinburgh, Scotland from May 17-20. This is a big research meeting dedicated to peripheral neuropathies and uniting scientists in the field. FPN’s Executive Director, Lindsay Colbert, went to this year’s meeting. She sat in many exciting talks about research projects that […]
Advocacy Day & the critical need for research dollars Thanks to all our Peripheral Neuropathy Awareness Week contributors From our live webinar participants who submitted great questions, to our social followers who shared content to educate on PN, and all those who talked to their community about their personal experience last week, thank you! Increased […]
Advocacy Day & the critical need for research dollars On March 18, FPN staff and board members traveled to Washington, D.C. to speak up for the 30 million Americans who have peripheral neuropathy (PN). Our visit was urgent because earlier in March, the U.S. Congress passed a bill that cut funding for medical research by 57%. Read […]
Protect PN research from proposed funding cuts Proposed cuts to federal research funding threaten critical studies across many conditions, including neuropathy. Research funding, which totals billions annually, supports essential work on nerve regeneration, pain management, and new treatments for PN. As soon as today, the House will be voting on a continuing resolution to fund […]
FPN funds scholarship award on CIPN Tiffany Li, PhD, has been awarded the 2025 Clinical Research Training Scholarship (CRTS) to support her important research on chemotherapy-induced peripheral neuropathy (CIPN). The CRTS is a multi-year scholarship program providing funding for emerging experts in neuropathy, supporting their efforts to advance treatments, prevention, or cures for neuropathy. Read […]
November is Diabetes Awareness Month, a time dedicated to raising awareness about the causes, risks, and management of diabetes. As the leading cause of peripheral neuropathy, diabetes can have serious implications for nerve health. This month, we’re focusing on education and prevention strategies to help you reduce your risk or manage diabetes more effectively. […]
October is Breast Cancer Awareness Month, a time to highlight the importance of early detection and treatment for breast cancer. In 2024, over 360,000 individuals in the U.S. will be diagnosed, making awareness and education crucial. A common treatment for breast cancer is chemotherapy, which can lead to a side effect known as chemotherapy-induced peripheral neuropathy […]